RAB3A and hepatocellular carcinoma: Further clinical analysis verified the significant difference in HCC metastasis between OGTLowRab3AHigh patients and OGTLowRab3ALow patients (p = 0.0017), and upregulated Rab3A in OGTHigh HCC patients conferred no significant improvement in vessel invasion (p = 0.55138) (Fig. 4g, Additional file 6: Table S2 and Additional file 7: Figure S5).